-
Study aim
-
Comparison of the effectiveness of hydrodissection combined with corticosteroids and open surgery in the treatment of moderate and severe carpal tunnel syndrome.
-
Design
-
Clinical trial, with two parallel groups, non-randomized, without blinding, on 40 patients
-
Settings and conduct
-
Patients with moderate to severe carpal tunnel syndrome who refer to physical medicine and rehabilitation or orthopedic clinics under the supervision of Isfahan University of Medical Sciences will be allocated to the surgery group if they wish to undergo surgery, and to the hydrodissection group if they do not agree to surgery or want to delay it for at least 6 months. In this study, only the data analyst is unaware of the patient grouping.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Moderate to severe carpal tunnel syndrome, age over 18, no injection treatment or physiotherapy and modality within the last three months. Exclusion criteria: Radiculopathy, plexopathy, peripheral neuropathy, uncontrolled systemic diseases.
-
Intervention groups
-
The first group received median nerve release through hydrodissection, utilizing 5 cc of 5% dextrose solution and 1 cc of triamcinolone, guided by ultrasound in a single session. Meanwhile, the second group was treated surgically with a longitudinal incision on the distal forearm along the fourth finger.
-
Main outcome variables
-
Visual analogue scale score, Boston carpal tunnel questionnaire score for pain and function, amplitude and latency of median nerve sensory and motor responses